Additional Listing

Summary by AI BETAClose X

Next 15 Group plc has applied to the London Stock Exchange for the admission of 36,389 new ordinary shares to AIM, to be issued in connection with long-term incentives for M Booth Health LLC. These new shares will rank pari passu with existing ordinary shares, and admission is expected by August 19, 2026. Following this issuance, the company will have 102,167,628 ordinary shares in issue, with no shares held in treasury.

Disclaimer*

 

14 August 2026

Next 15 Group plc

(“Next 15” or the “Company”)

Additional Listing

Next 15 Group plc announces that application has been made to the London Stock Exchange for 36,389 new ordinary shares of 2.5 pence each in the Company (‘Ordinary Shares’) to be admitted to AIM.

An application has been made in respect of the Ordinary Shares to be issued in connection with the vesting of certain long-term incentives for M Booth Health LLC.

These new Ordinary Shares will, upon issue, rank pari passu with the existing ordinary share capital of the Company. It is expected that admission will become effective by 19 August 2026.

Following the issue and allotment of these new Ordinary Shares as described above, the Company will have 102,167,628 Ordinary Shares in issue. No shares are held in treasury.

Enquiries

For further information, please contact:

Next 15 Group plc

Mark Sanford, General Counsel and Company Secretary

+44 (0) 7590 928 794

 

Deutsche Numis (Nomad & Joint Broker)

+44 (0)20 7260 1000

Mark Lander

Hugo Rubinstein

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Ben Wright

Mark Whitmore

 

MHP

Oliver Hughes

Eleni Menikou

Lucy Gibbs


LEI: 213800BK9MBUZUUPMZ63

 

+44 (0)7701 308 818

Next15@mhpgroup.com

 

UK 100

Latest directors dealings